Two Sigma Investments, LP Kaleido Biosciences, Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.82 - $8.72 $215,770 - $323,285	-37,074 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.2 - $16.82 $266,932 - $623,584	37,074 New	37,074 $300,000
Q4 2020 Feb 16, 2021	SELL	$5.77 - $11.33 $75,010 - $147,290	-13,000 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$5.09 - $11.07 $128,364 - $279,174	-25,219 Reduced 65.99%	13,000 $144,000
Q2 2020 Aug 14, 2020	BUY	$4.62 - $8.01 $176,571 - $306,134	38,219 New	38,219 $284,000

2.65K

Ticker KLDO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,622,600
Description
Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the tr...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.